Health Economics and Outcomes Research (HEOR)

  • Home
  • Newsroom
  • Health Economics and Outcomes Research (HEOR)

Health Economics and Outcomes Research (HEOR)

  1. lut 28, 2025

What Does the 'Health Economics and Outcomes Research (HEOR)’ Mean?

Health Economics and Outcomes Research (HEOR) is a multidisciplinary field that evaluates the economic impact and patient outcomes of healthcare interventions. It combines principles from economics, epidemiology, and health policy to assess the value of medical treatments, drugs, and healthcare services.

HEOR studies analyze factors such as cost-effectiveness, quality of life improvements, and overall healthcare resource utilization. The findings from HEOR are used by healthcare providers, payers, and policymakers to make informed decisions about resource allocation, treatment guidelines, and reimbursement policies.

Why Is the 'Health Economics and Outcomes Research (HEOR)’ Important in Clinical Research?

HEOR plays a crucial role in clinical research by providing a comprehensive understanding of the real-world impact of medical interventions. It helps researchers and stakeholders evaluate not only the clinical efficacy of treatments but also their economic viability and effect on patient-reported outcomes, ensuring a more holistic approach to healthcare decision-making.

The importance of HEOR in clinical research is further emphasized by its ability to bridge the gap between clinical trial results and real-world application. By incorporating economic analyses and patient-centered outcomes, HEOR enables more informed decisions about resource allocation, treatment guidelines, and reimbursement policies, ultimately leading to more efficient and effective healthcare systems.

Good Practices and Procedures

  1. Conduct systematic literature reviews to identify relevant economic models and patient-reported outcome measures specific to the disease area being studied.
  2. Develop and validate disease-specific economic models that incorporate both direct and indirect costs associated with treatments and health outcomes.
  3. Utilize real-world evidence and claims data to supplement clinical trial results and enhance the generalizability of HEOR findings.
  4. Implement sensitivity analyses to account for uncertainties in cost estimates, clinical outcomes, and patient preferences across different healthcare settings.
  5. Engage with stakeholders, including patients, clinicians, and payers, throughout the HEOR process to ensure relevance and applicability of research outcomes.

Related Terms

Read more

Axcellant partners with Prometheus MedTech.AI to accelerate AI-powered cardiac diagnostics

We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…

Axcellant at EANM 2025: What We Brought Back from Barcelona

The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…

Radioisotopes in Medicine: Clinical Applications, Safety, and Regulatory Considerations

The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…